Skip to content
★ Sign in to follow
Hygeia Healthcare Holdings Co., Ltd. logo

Hygeia Healthcare Holdings Co., Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$5.7BHealth Care

No insider purchase over the last 90 days. The latest, by ZHU Yiwen, was filed 14 May 2026.

Hygeia Healthcare Holdings Co., Ltd.: what insiders have been doing

Hygeia Healthcare Holdings Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. 1 insider has disclosed 5 filings since 8 November 2025.

The flow runs one way only: 1 insider bought (5 purchases totalling €4.5M) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €2.1M, the purchase published on 11 May 2026 by ZHU Yiwen is the largest of the period (0.32% of market cap). The buyers include 1 senior executive.

For context, the typical company on the same exchange (median of 1,323 companies) published 4 filings over the same period, against 5 filings here. Looking back to 2020, when coverage begins, insiders filed 29 purchases and 5 sales.

In the case of 2 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 179 days ago, on 14 May 2026. Half of the filings or more reach the HKEX feed on the day of the trade. Until a filing is published, the market cannot know about the trade.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
65
Thresholds
n/a
Buy Volume
€24M
29 ops. · all time
Sell Volume
€1M
5 ops. · all time

Who traded when

BuySale
ZHU Yiwen9 buys

Since the insiders bought

  • Filed 14 May 2026 · 179 days ago · €1.4M
    -2.6%
    Entry HK$11.28 · Close 06 Nov 2026 HK$10.99
  • Filed 19 Jan 2024 · 1025 days ago · €537k
    -50.4%
    Entry HK$27.30 · Close at T+365 HK$13.54

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 15,181 of 26,911 companies
47.7
score / 100
Value
57
Quality
38
FCF yld8.2%
Earn yld2.9%
EV/EBITDA11.6x
ROE2.5%
Gross mgn26%
Net mgn4.1%
Debt/EBITDA3.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$9.39
Analyst consensus
15 analysts
1.67/5
HK$10.75Target HK$16.32(+74%)HK$25.51
Income statement
RevenueHK$4B
Gross profitHK$1B26% margin
EBITDAHK$700.6M17% margin
Net incomeHK$164.5M4.4% margin
Valuation
PER (trailing)29.3x
PER (forward)9.6x
P/Book0.7x
Beta0.40
Balance sheet & cash
Market capHK$5.7B
Total debtHK$2.4B
Free Cash FlowHK$466.4M
Debt / Equity33%
Profitability & ownership
ROE2.5%
ROA3.9%
% insiders48.1%
% institutions21.9%
Last declaration on 18 May 2026
Declarations65 total
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    13M HKD26HKEX
    1,138,200 shares@ HK$11.5690.22% mcap31.7% of flowShareXHKGHKEX:DA20260518E00140
    Canonical exit: 12 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    13M HKD26HKEX
    1,138,200 shares@ HK$11.5690.22% mcap31.7% of flowShareXHKGHKEX:DA20260514E00356
    Canonical exit: 12 Aug 2026 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    19M HKD28HKEX
    1,600,000 shares@ HK$11.9180.32% mcap45.5% of flowShareXHKGHKEX:DA20260512E00318
    Canonical exit: 9 Aug 2026 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    6M HKD24HKEX
    519,000 shares@ HK$11.890.10% mcap14.8% of flowShareXHKGHKEX:DA20260512E00316
    Canonical exit: 6 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    19M HKD28HKEX
    1,600,000 shares@ HK$11.9180.32% mcap45.5% of flowShareXHKGHKEX:DA20260511E00286
    Canonical exit: 9 Aug 2026 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    3M HKD24HKEX
    260,400 shares@ HK$11.50580.051% mcap7.2% of flowShareXHKGHKEX:DA20260509E00023
    Canonical exit: 4 Aug 2026 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    358,720 HKD23HKEX
    30,400 shares@ HK$11.800.0061% mcap0.9% of flowShareXHKGHKEX:DA20260509E00024
    Canonical exit: 5 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    6M HKD12HKEX
    519,000 shares@ HK$11.890.10% mcap14.8% of flowShareXHKGHKEX:DA20260508E00333
    Canonical exit: 6 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    358,720 HKD11HKEX
    30,400 shares@ HK$11.800.0061% mcap0.9% of flowShareXHKGHKEX:DA20260508E00317
    Canonical exit: 5 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD12HKEX
    260,400 shares@ HK$11.50580.051% mcap7.2% of flowShareXHKGHKEX:DA20260506E00350
    Canonical exit: 4 Aug 2026 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    23M HKD25HKEX
    1,664,800 shares@ HK$13.828420.3% of flowShareXHKGHKEX:DA20250919E00103
    Canonical exit: 17 Dec 2025 (T+90)
  • ▲
    DirectorExecutives
    23M HKD12HKEX
    1,664,800 shares@ HK$13.828411.5% of flowShareXHKGHKEX:DA20250918E00370
    Canonical exit: 17 Dec 2025 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    5M HKD23HKEX
    390,600 shares@ HK$12.79614.8% of flowShareXHKGHKEX:DA20250409E00435
    Canonical exit: 6 Jul 2025 (T+90)
  • ▲
    DirectorExecutives
    5M HKD23HKEX
    390,600 shares@ HK$12.79612.7% of flowShareXHKGHKEX:DA20250408E00331
    Canonical exit: 6 Jul 2025 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    5M HKD23HKEX
    357,000 shares@ HK$14.004.8% of flowShareXHKGHKEX:DA20250401E00298
    Canonical exit: 26 Jun 2025 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    3M HKD23HKEX
    258,400 shares@ HK$13.39973.3% of flowShareXHKGHKEX:DA20250401E00299
    Canonical exit: 29 Jun 2025 (T+90)
  • ▲
    DirectorExecutives
    3M HKD11HKEX
    258,400 shares@ HK$13.39971.9% of flowShareXHKGHKEX:DA20250331E00162
    Canonical exit: 29 Jun 2025 (T+90)
  • ▲
    DirectorExecutives
    5M HKD11HKEX
    357,000 shares@ HK$14.002.7% of flowShareXHKGHKEX:DA20250331E00159
    Canonical exit: 26 Jun 2025 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    114,187,436 sharesShareXHKGHKEX:DA20241002E00001
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    547,400 HKD23HKEX
    18,400 shares@ HK$29.750.5% of flowShareXHKGHKEX:DA20240404E00199
    Canonical exit: 1 Jul 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    13M HKD24HKEX
    440,200 shares@ HK$29.5412.4% of flowShareXHKGHKEX:DA20240404E00200
    Canonical exit: 2 Jul 2024 (T+90)
  • ▲
    DirectorExecutives
    13M HKD12HKEX
    440,200 shares@ HK$29.547.0% of flowShareXHKGHKEX:DA20240403E00493
    Canonical exit: 2 Jul 2024 (T+90)
  • ▲
    DirectorExecutives
    547,400 HKD11HKEX
    18,400 shares@ HK$29.750.3% of flowShareXHKGHKEX:DA20240403E00492
    Canonical exit: 1 Jul 2024 (T+90)
  • ▲
    DirectorExecutives
    9M HKD23HKEX
    325,200 shares@ HK$27.154.7% of flowShareXHKGHKEX:DA20240123E00276
    Canonical exit: 21 Apr 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by ZHU Yiwen, counted once

    9M HKD24HKEX
    325,200 shares@ HK$27.158.4% of flowShareXHKGHKEX:DA20240123E00321
    Canonical exit: 21 Apr 2024 (T+90)

25 of 65 declarations

About Hygeia Healthcare Holdings Co., Ltd.

Hygeia Healthcare Holdings Co., Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the healthcare and pharmaceutical sector. It focuses on providing healthcare services and pharmaceutical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations